HealthDay - TUESDAY, Oct. 5 (HealthDay News) -- Adding a new vaccine to standard therapy extended survival for people with the most deadly type of brain cancer in a small study.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.